Treatment of HCM mice with TGF-β-neutralizing antibodies markedly reduces the expression of periostin, which promotes differentiation into fibroblasts and improves cardiac hypertrophy (Teekakirikul et al., 2010). The gene discussed is TGFB1; the disease is cardiac hypertrophy.